Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.vaccine.2022.02.046

http://scihub22266oqcxt.onion/10.1016/j.vaccine.2022.02.046
suck pdf from google scholar
35183386!8841157!35183386
unlimited free pdf from europmc35183386    free
PDF from PMC    free
html from PMC    free
PDF vom PMID35183386  :  Publisher

suck abstract from ncbi

pmid35183386
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low #MMPMID35183386
  • Gaffney KK; Jana Broadhurst M; Brett-Major DM
  • Vaccine 2022[Mar]; 40 (12): 1691-1694 PMID35183386show ga
  • Vaccines against coronavirus disease 2019 (COVID-19) first became available in the United States and Europe outside clinical trials in December 2020, when administration began in high-priority populations such as healthcare workers and long-term care residents. [1] Since that time, global rollout progresses with wide variation in vaccination rates by country. [2] Depending upon product and SARS-CoV-2 variant, vaccine efficacies against infection range from approximately 70 to well over 90%, higher against severe disease. Well-resourced settings are starting to focus on booster doses among high risk persons, and locations with higher vaccination rates appear to have less COVID-19 patient and community impact. Yet, in every setting, primary vaccination to as many persons as possible remains incredibly important to effective pandemic risk management. Why this is the case, why even in settings with comparatively high vaccination rates and boosting we still should make the case that more primary vaccination matters can be answered by remembering mumps, and applying those lessons to promoting vaccine access.
  • |*COVID-19/prevention & control[MESH]
  • |*Mumps/prevention & control[MESH]
  • |COVID-19 Vaccines[MESH]
  • |Humans[MESH]
  • |SARS-CoV-2[MESH]
  • |United States/epidemiology[MESH]
  • |Vaccination[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1691 12.40 2022